Tweet #605814709036544001
RT @CancerNetwrk: Nivolumab Trumps Ipilimumab as First-Line #Melanoma Therapy bit.ly/1K2mPdW #cancer #skincancer #oncology #ASCO15
RT @CancerNetwrk: Nivolumab Trumps Ipilimumab as First-Line #Melanoma Therapy bit.ly/1K2mPdW #cancer #skincancer #oncology #ASCO15